Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1-infected Individuals
Active, no longer recruiting
Phase of Trial: Phase 0
Latest Information Update: 09 Jul 2019
At a glance
- Drugs Enfuvirtide (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 03 Jul 2019 Planned End Date changed from 1 Jul 2021 to 1 Sep 2020.
- 03 Jul 2019 Status changed from recruiting to active, no longer recruiting.
- 08 Mar 2016 Planned End Date changed from 1 Jul 2017 to 1 Jul 2021, as reported by ClinicalTrials.gov record.